HHS’ Proposed “Action Plan” On Adverse Events
This article was originally published in RPM Report
Executive Summary
Here is the “Conclusion & Next Steps” section for HHS’ draft National Action Plan for Adverse Drug Event Prevention. The report focuses on three pharmaceutical classes—opioids, antidiabetics and anticoagulants—and catalogs HHS activities to control and reduce adverse reactions.